D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 83 Citations 28,292 400 World Ranking 10365 National Ranking 198

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Internal medicine
  • Gene

Prostate cancer, Pathology, Prostate, Prostatectomy and Internal medicine are his primary areas of study. Prostate cancer is a subfield of Cancer that Lars Egevad explores. His work carried out in the field of Pathology brings together such families of science as Consensus conference and High-grade prostatic intraepithelial neoplasia.

His Prostate study integrates concerns from other disciplines, such as Tumor progression, Angiogenesis, Metastasis and Adenocarcinoma. He has researched Prostatectomy in several fields, including Proportional hazards model, Surgical pathology, Radiation therapy and Anatomical pathology. His Internal medicine research includes themes of Endocrinology, Surgery and Oncology.

His most cited work include:

  • The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma (2002 citations)
  • International network of cancer genome projects (1611 citations)
  • The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System. (1209 citations)

What are the main themes of his work throughout his whole career to date?

Lars Egevad focuses on Prostate cancer, Pathology, Prostate, Internal medicine and Prostatectomy. Prostate cancer is the subject of his research, which falls under Cancer. His Pathology study frequently involves adjacent topics like Adenocarcinoma.

His study looks at the relationship between Prostate and fields such as Gynecology, as well as how they intersect with chemical problems. His Internal medicine study combines topics in areas such as Endocrinology and Oncology. His Prostatectomy study incorporates themes from Surgery, Proportional hazards model and Lymph node.

He most often published in these fields:

  • Prostate cancer (63.07%)
  • Pathology (43.97%)
  • Prostate (39.95%)

What were the highlights of his more recent work (between 2018-2021)?

  • Prostate cancer (63.07%)
  • Pathology (43.97%)
  • Prostate (39.95%)

In recent papers he was focusing on the following fields of study:

Lars Egevad spends much of his time researching Prostate cancer, Pathology, Prostate, Grading and Cancer. His biological study focuses on Prostatectomy. He focuses mostly in the field of Pathology, narrowing it down to matters related to Molecular pathology and, in some cases, Penile cancer, Urogenital cancer, Androgen receptor, Ki-67 and DNA mismatch repair.

His research in Prostate intersects with topics in Carcinoma, MEDLINE, Medical physics and Perineural invasion. His Grading research also works with subjects such as

  • Gleason grading system, Cribriform Carcinoma, Fisher's exact test, Papillary pattern and Gleason Score 6 most often made with reference to Gleason grade,
  • Consensus conference that connect with fields like Targeted therapy,
  • General surgery which connect with Treatment response. His work on Watchful waiting as part of general Cancer study is frequently linked to Test, therefore connecting diverse disciplines of science.

Between 2018 and 2021, his most popular works were:

  • Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study. (100 citations)
  • Outcomes of Primary Lymph Node Staging of Intermediate and High Risk Prostate Cancer with 68 Ga-PSMA Positron Emission Tomography/Computerized Tomography Compared to Histological Correlation of Pelvic Lymph Node Pathology (34 citations)
  • Grading of renal cell carcinoma. (33 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Internal medicine
  • Gene

Lars Egevad mainly investigates Prostate cancer, Pathology, Grading, Prostate and Molecular pathology. He does research in Prostate cancer, focusing on Prostatectomy specifically. Within one scientific family, Lars Egevad focuses on topics pertaining to Consensus conference under Prostatectomy, and may sometimes address concerns connected to Medical physics, Prostate carcinoma, Gleason Score 6, Gleason grade and Gleason grading system.

His study on Disease, Immunohistochemistry and Clear cell is often connected to Low resource as part of broader study in Pathology. Lars Egevad combines subjects such as Biopsy and Ai systems, Artificial intelligence with his study of Grading. In his study, Invasive carcinoma is inextricably linked to Carcinoma, which falls within the broad field of Prostate.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma

Geert J.L.H. van Leenders;Theodorus H. van der Kwast;David J. Grignon;Andrew J. Evans.
The American Journal of Surgical Pathology (2005)

2742 Citations

The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.

Jonathan I. Epstein;Lars Egevad;Mahul B. Amin;Brett Delahunt.
The American Journal of Surgical Pathology (2015)

2573 Citations

International network of cancer genome projects

Thomas J. Hudson;Thomas J. Hudson;Warwick Anderson;Axel Aretz;Anna D. Barker.
(2010)

1839 Citations

Gene expression profiling identifies clinically relevant subtypes of prostate cancer

Jacques Lapointe;Chunde Li;John P. Higgins;Matt van de Rijn.
Proceedings of the National Academy of Sciences of the United States of America (2004)

1549 Citations

A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score.

Jonathan I. Epstein;Michael J. Zelefsky;Daniel D. Sjoberg;Joel B. Nelson.
European Urology (2016)

1247 Citations

The International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasia

John R. Srigley;Brett Delahunt;John N. Eble;Lars Egevad.
The American Journal of Surgical Pathology (2013)

1097 Citations

The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic Parameters

Brett Delahunt;John C. Cheville;Guido Martignoni;Peter A. Humphrey.
The American Journal of Surgical Pathology (2013)

615 Citations

The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer

M. Norberg;L. Egevad;L. Holmberg;P. Sparén.
Urology (1997)

590 Citations

CD4+CD25high T Cells Are Enriched in the Tumor and Peripheral Blood of Prostate Cancer Patients

Ashley M. Miller;Kajsa Lundberg;Volkan Özenci;Alison H. Banham.
Journal of Immunology (2006)

542 Citations

Tumor associated macrophages in human prostate cancer: relation to clinicopathological variables and survival

I F Lissbrant;P Stattin;P Wikstrom;J E Damber.
International Journal of Oncology (2000)

450 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Lars Egevad

Jonathan I. Epstein

Jonathan I. Epstein

Johns Hopkins University

Publications: 180

Liang Cheng

Liang Cheng

Indiana University

Publications: 151

Rodolfo Montironi

Rodolfo Montironi

Marche Polytechnic University

Publications: 148

Antonio Lopez-Beltran

Antonio Lopez-Beltran

University of Córdoba

Publications: 119

Markus Graefen

Markus Graefen

Universität Hamburg

Publications: 97

Mark A. Rubin

Mark A. Rubin

University of Bern

Publications: 85

Pär Stattin

Pär Stattin

Uppsala University

Publications: 77

Shahrokh F. Shariat

Shahrokh F. Shariat

Medical University of Vienna

Publications: 72

Francesco Montorsi

Francesco Montorsi

Vita-Salute San Raffaele University

Publications: 71

Alberto Briganti

Alberto Briganti

Vita-Salute San Raffaele University

Publications: 68

Elio Riboli

Elio Riboli

Imperial College London

Publications: 65

Rudolf Kaaks

Rudolf Kaaks

German Cancer Research Center

Publications: 64

Stephen J. Freedland

Stephen J. Freedland

Cedars-Sinai Medical Center

Publications: 64

Hashim U. Ahmed

Hashim U. Ahmed

Imperial College Healthcare NHS Trust

Publications: 62

Monique J. Roobol

Monique J. Roobol

Erasmus MC

Publications: 61

Paul C. Boutros

Paul C. Boutros

University of California, Los Angeles

Publications: 60

Trending Scientists

Urbano Nunes

Urbano Nunes

University of Coimbra

Minhao Zhu

Minhao Zhu

Southwest Jiaotong University

ChangKyoo Yoo

ChangKyoo Yoo

Kyung Hee University

Lothar Helm

Lothar Helm

École Polytechnique Fédérale de Lausanne

Wolf U. Blanckenhorn

Wolf U. Blanckenhorn

University of Zurich

Beatriz Martínez-López

Beatriz Martínez-López

University of California, Davis

Walter Berger

Walter Berger

Medical University of Vienna

Janet S. Herman

Janet S. Herman

University of Virginia

Bart Nijssen

Bart Nijssen

University of Washington

Michael A. Southam-Gerow

Michael A. Southam-Gerow

Virginia Commonwealth University

Grazyna Kochanska

Grazyna Kochanska

University of Iowa

Luciano Gattinoni

Luciano Gattinoni

University of Göttingen

Anne Marie Goetz

Anne Marie Goetz

New York University

Michael E. Fisher

Michael E. Fisher

University of Maryland, College Park

Something went wrong. Please try again later.